Infusio Glucosi Imuna

Glucose Monohydrate, the active ingredient in Infusio Glucosi Imuna, is a carbohydrate solution presented as an intravenous solution for intravenous use. It provides rapid glucose supplementation for patients who need immediate energy, such as those experiencing hypoglycemia or undergoing surgical procedures.

GNH USA supplies Infusio Glucosi Imuna as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Infusio Glucosi Imuna is used to address conditions that require immediate glucose supplementation or fluid support. - Hypoglycemia: restores blood glucose levels quickly in patients with low plasma glucose. - Perioperative fluid management: supplies energy and maintains fluid balance during surgery. - Parenteral nutrition: provides a carbohydrate source in total parenteral nutrition regimens. - Electrolyte replacement: serves as a carrier for electrolytes in intravenous therapy.

Infusio Glucosi Imuna may be associated with a range of adverse reactions.

Common Side Effects: - Hyperglycemia: elevated blood glucose levels. - Local irritation: discomfort or redness at the infusion site. - Phlebitis: inflammation of the vein used for infusion. - Nausea: feeling of sickness or urge to vomit. - Headache: mild to moderate head pain. - Electrolyte imbalance: shifts in serum electrolytes.

Serious or Rare Side Effects: - Severe hyperglycemia: markedly high glucose requiring medical intervention. - Anaphylactic reaction: rare severe allergic response. - Volume overload: excessive fluid leading to pulmonary edema. - Hyperosmolar coma: extreme hyperosmolar state causing neurological impairment. - Infection at infusion site: bacterial contamination causing local or systemic infection. - Hypokalemia: low potassium levels due to rapid glucose infusion.

When using Infusio Glucosi Imuna, clinicians should observe several safety measures. - Blood glucose assessment: verify baseline glucose before infusion. - Electrolyte monitoring: check serum electrolytes during and after therapy. - Renal function: adjust infusion rate in patients with impaired kidney function. - Diabetes control: avoid use in patients with uncontrolled diabetes without close monitoring. - Aseptic technique: maintain sterility during preparation and administration. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Glucose infusion can interact with other medications and clinical conditions.

Major Interactions (Avoid): - Insulin therapy: concurrent use may cause severe hypoglycemia. - Sodium bicarbonate: combined administration can increase solution osmolarity. - Loop diuretics: may exacerbate electrolyte disturbances.

Moderate Interactions (Monitor Closely): - Beta‑blockers: can mask hypoglycemia symptoms. - Corticosteroids: may raise blood glucose levels. - ACE inhibitors: affect renal handling of fluids and electrolytes. - Parenteral nutrition lipids: may require adjustment of carbohydrate load.